Biomarkers as disease definition: Mantle cell lymphoma as an example : Pathways to Translation of Proteomics into Clinical PracticeVAN KRIEKEN, Johan H. J. M; JANSEN, Corine; HEBEDA, Konnie M et al.Proteomics. Clinical applications (Print). 2010, Vol 4, Num 12, pp 922-925, issn 1862-8346, 4 p.Article

Current treatment approaches for mantle-cell lymphomaWITZIG, Thomas E.Journal of clinical oncology. 2005, Vol 23, Num 26, pp 6409-6414, issn 0732-183X, 6 p.Article

Gi manifestations of mantle cell lymphomaCHOR SANG CHIM; HU, Wayne H. C; LOONG, Florence et al.Gastrointestinal endoscopy. 2003, Vol 58, Num 6, pp 931-933, issn 0016-5107, 3 p.Article

Mantle cell lymphoma : Lymphoid biology and diseasesBERTONI, Francesco; ZUCCA, Emanuele; CAVALLI, Franco et al.Current opinion in hematology. 2004, Vol 11, Num 6, pp 411-418, issn 1065-6251, 8 p.Article

Management of Mantle Cell Lymphoma in the Elderly: Current and Potential StrategiesVIGNON, Marguerite; VENON, Marie-Dominique; HERMINE, Olivier et al.Drugs & aging. 2013, Vol 30, Num 12, pp 979-986, issn 1170-229X, 8 p.Article

Prognostic role of SOX11 in a population-based cohort of mantle cell lymphomaNYGREN, Lina; BAUMGARTNER WENNERHOLM, Stefanie; KLIMKOWSKA, Monika et al.Blood. 2012, Vol 119, Num 18, pp 4215-4223, issn 0006-4971, 9 p.Article

Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphomaLEONARD, John P; LACASCE, Ann S; NEUBERG, Donna S et al.Blood. 2012, Vol 119, Num 20, pp 4597-4607, issn 0006-4971, 11 p.Article

Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphomaKRIDEL, Robert; MEISSNER, Barbara; TAN, King et al.Blood. 2012, Vol 119, Num 9, pp 1963-1971, issn 0006-4971, 9 p.Article

FTY720 increases CD74 expression and sensitizes mantle cell lymphoma cells to milatuzumab-mediated cell deathALINARI, Lapo; MAHONEY, Emilia; TOWNS, William H et al.Blood. 2011, Vol 118, Num 26, pp 6893-6903, issn 0006-4971, 11 p.Article

Bone marrow involvement in mantle cell lymphomaNARESH, Kikkeri; HARTLEY, Sarah; MACDONALD, Donald et al.American journal of hematology. 2010, Vol 85, Num 6, issn 0361-8609, p. 446Article

Temsirolimus in Mantle Cell Lymphoma and Other Non-Hodgkin Lymphoma SubtypesHESS, Georg; SMITH, Sonali M; BERKENBLIT, Anna et al.Seminars in oncology. 2009, Vol 36, Num 6, issn 0093-7754, S37-S45, SUP3Article

Bilateral Panocular Involvement With Mantle-Cell LymphomaCHAPPELOW, Aimee V; SINGH, Arun D; PEREZ, Victor L et al.Journal of clinical oncology. 2008, Vol 26, Num 7, pp 1167-1167, issn 0732-183X, 1 p.Article

Immunotherapy in mantle cell lymphoma : Anti-CD20-based therapy and beyondYUHONG ZHOU; LIANG ZHANG; ROMAGUERA, Jorge et al.American journal of hematology. 2008, Vol 83, Num 2, pp 144-149, issn 0361-8609, 6 p.Article

Skin manifestation of mantle cell lymphomaMOTEGI, Sei-Ichiro; OKADA, Etsuko; NAGAI, Yayoi et al.EJD. European journal of dermatology. 2006, Vol 16, Num 4, pp 435-438, issn 1167-1122, 4 p.Article

Integrating monoclonal antibodies into the management of mantle cell lymphomaBERINSTEIN, Neil L; MANGEL, Joy.Seminars in oncology. 2004, Vol 31, pp 2-6, issn 0093-7754, 5 p., SUP2Article

Sequestration of p27^Kip1 protein by cyclin dl in typical and blastic variants of mantle cell lymphoma (MCL): implications for pathogenesisQUINTANILLA-MARTINEZ, Leticia; DAVIES-HILL, Theresa; FEND, Falko et al.Blood. 2003, Vol 101, Num 8, pp 3181-3187, issn 0006-4971, 7 p.Article

Cytogenetic findings in blastoid mantle cell lymphomaKHOURY, Joseph D; SEN, Filiz; ABRUZZO, Lynne V et al.Human pathology. 2003, Vol 34, Num 10, pp 1022-1029, issn 0046-8177, 8 p.Article

Mantle cell lymphoma in leukaemic phaseLUSH, Richard J; SOWTER, David P; HAYNES, Andrew P et al.British journal of haematology. 2002, Vol 117, Num 1, issn 0007-1048, p. 1Article

The effect of Rituximab on patients with follicular and mantle-cell lymphomaGHIELMINI, M; SCHMITZ, S.-F. H; CERNY, T et al.Annals of oncology. 2000, Vol 11, pp 123-126, issn 0923-7534, SUP1Conference Paper

Retrospective analysis of mantle cell lymphoma : Experience of the Gruppo Italiano per lo Studio dei Linfomi (GISL)CALLEA, V; CLO, V; MORABITO, F et al.Haematologica - Journal of hematology. 1998, Vol 83, Num 11, pp 993-997Article

Mantle-cell lymphoma : Classification and therapeutic implicationsFISHER, R. I.Annals of oncology. 1996, Vol 7, pp S35-S39, issn 0923-7534, SUP6Article

Prognostic impact of monocyte count at presentation in mantle cell lymphoma ― response to George et alVON HOHENSTAUFEN, Kathrin Aprile; CONCONI, Annarita; DE CAMPOS, Cassio Polpo et al.British journal of haematology. 2014, Vol 164, Num 6, pp 893-894, issn 0007-1048, 2 p.Article

Prognostic impact of monocyte count at presentation in mantle cell lymphomaGEORGE, Anupkumar; PRINCE, Henry Miles; SZER, Jeff et al.British journal of haematology. 2014, Vol 164, Num 6, pp 890-893, issn 0007-1048, 4 p.Article

Treatment of Older Patients with Mantle-Cell LymphomaKLUIN-NELEMANS, H. C; HOSTER, E; COIFFIER, B et al.The New England journal of medicine. 2012, Vol 367, Num 6, pp 520-531, issn 0028-4793, 12 p.Article

Does more intensive therapy have effects on mantle cell lymphoma? A clinical experience from the Lymphoma Treatment Study Group in JapanMIURA, Katsuhiro; TAKASAKI, Hirotaka; TERASAKI, Yasushi et al.International journal of hematology. 2011, Vol 93, Num 5, pp 684-686, issn 0925-5710, 3 p.Article